Future studies would benefit from using targeted epigenetics assays such as single cell RNA-seq (scRNA-seq) or chromatin immunoprecipitation-seq (ChIP-seq) using brain ECs to see if MMP-3 inhibition does indeed modulate expression of these genes in the endothelium or in other brain cell types following stroke. Here, MMP3 is linked to stroke disorder.